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Zona zoster is rarely observed in patients with malignancy; when present, it follows a dermatomal fashion. Involvement of widely
separated regions is very rare. Hereby, zona zoster causing enlarged intramammary lymph nodes (IMLN) in the opposite breast
is reported for the ﬁrst time in literature. The masses were hypoechoic on US with no hilum and hypervascular on color Doppler
US. MRI showed hypointense masses with type 3 time-intensity curve and adjacent vessel sign. The complete regression of the
nodes after the antiviral therapy conﬁrmed the diagnosis. In breast cancer patients, IMLN enlargements may mimic breast cancer
metastasis, and zona zoster infection of the mastectomy site may present with contralateral IMLN enlargement due to altered
lymphatic drainage. When breast US is not suﬃcient for the diﬀerential diagnosis, breast MRI may warrant proper diagnosis, and
prevent unnecessary biopsies. Antiviral treatment with followup would be suﬃcient for management.
1.Introduction
Zona zoster is caused by the varicella zoster virus that re-
mains latent in sensory dorsal root ganglion cells after the
ﬁrst infection or immunization [1]. In immunocompromis-
ed patients, the virus travels down the sensory nerve into
the skin which is clinically characterized by several groups of
painful vesicles situated within the distribution of the spinal
sensory nerve [2]. In the classical clinical picture, zona zoster
follows a dermatomal fashion. Cases of bilateral involvement
and synchronous zosters involving two widely separated
regions are rarely reported [2, 3]. Although patients with
malignancy are more likely to develop zona zoster, occur-
rence after breast cancer is rare [4, 5]. To our knowledge,
zona zoster of the mastectomy site causes intramammary
lymph node (IMLN) enlargement in the opposite breast
which has not been reported in the literature so far. Hereby,
we present a breast cancer patient who developed zona zoster
infectionatthemastectomysite,causingIMLNenlargements
in the opposite breast, which may be mistaken as breast
cancer metastasis.
2.CaseReport
A 70-year-old breast carcinoma patient was referred for her
routine radiological followup. Within the follow-up period
the patient had developed painful skin lesions on the mastec-
tomy side in a dermatomal distribution of two-week dura-
tion with multiple erythematous ﬁrm papulo-nodular les-
ions arranged along the T-4 segment dermatome, extending
from left mammary region to the left scapular region.
The patient had underwent left simple mastectomy and
axillary dissection due to breast carcinoma a year ago, and
the histopathology revealed moderately diﬀerentiated inva-
sive ductal carcinoma sized 2.4cm, and 21 out of 26 axil-
lary lymph nodes were metastatic. Pathological stage was
pT2N3M0. Tumor cells were positive both for estrogen and
progesterone receptors and negative for CerbB2. She had
receivedadjuvantchemotherapyconsistedof4cyclesofadri-
ablastin-cyclophosphamide, following 4 cycles of docetaxel
and 5000cGy external radiotherapy to chest wall and
regionallymphnodes.Anastrazolwasstartedafterradiother-
apy.2 Case Reports in Oncological Medicine
Figure 1: Hypoechoic, mass with lobular contours is observed
hypervascular on color Doppler US at the lower outer quadrant at
the right breast.
Mammography of the right breast revealed retroareolar
ﬁbroglandular densities with no remarkable additional ab-
normalities. On ultrasound (13–5MHz wideband multi-
Hertz transducer, Siemens Sonoline Antares, California,
USA) 7mm, 3mm, and 5mm hypoechoic, nodular masses
withlobularcontourswereidentiﬁedatlowerouterquadrant
near to the areola in the right breast. On color Doppler US,
the masses exhibited increased internal and capsular vascula-
risation (Figure 1). MRI was performed in an open-bore
design 1.5T MR unit (Magnetom Espree with Syngo MR B15
software;Siemens,Erlangen,Germany)byusingabilateral8-
channel breast matrix coil. On MRI, the nodules were hypoi-
ntense on T1- and T2-weighted images, and the margins
were smooth and lobular with an adjacent vessel sign. On
dynamic series the lesions exhibited homogeneous rapid
initial rise over 100%, and minimal washout was observed
(Figure 2). Because of extremely intense initial enhancement
during the ﬁrst 1-2 minutes that is well above the usual range
for invasive cancers [6], the radiological diagnosis was pro-
bable intramammary lymph node enlargement due to zona
zoster infection of the mastectomy site.
The patient was started on one-week acyclovir treatment
for zona zoster infection. Control US exam after one month
showed total regression of the masses, and the patient is
symptom-free for 2 years now.
3. Discussion
Our case had shown that, in breast cancer patients, zona
zostermayfollowanatypicalcourseandpresentwithcontra-
lateral enlarged IMLNs. To our knowledge, this is the ﬁrst re-
ported case of contralateral IMLN enlargement occurring
afterzonazosterinfectionofthemastectomysite.Theenlarg-
ement of IMLNs could mimic metastasis; therefore clinical
data is important for the diﬀerential diagnosis.
The reported prevalence of IMLNs is about 2%–28%
[7, 8], and they represent a potential extra-axillary site of
regional breast cancer metastasis. Similar to the other lymph
nodes throughout the body, infections may cause IMLN
enlargement. Unlike other infections, typical distribution
pattern of the zoster infection is observed along the
nerve axis. Contralateral breast is innervated by another
dermatome, which is thought to be free of infection. Altered
lymphoid drainage after mastectomy may be a possible
explanation to the contralateral IMLN enlargement in our
case.
Our patient had a history of breast cancer treatment with
chemotherapy and external radiotherapy to chest wall and
regional lymph nodes. It can be speculated that she was un-
der an immunosuppressed state because of her previous ch-
emotherapy, which may have led to defective cellular immu-
ne response and the development of zona zoster. There are
some studies reporting higher occurrence of zona zoster
ranked 1.9–3.7% in comparison to normal population after
receiving radiotherapy [9, 10]. Indeed, part of patients in-
cluded in these studies received chemotherapy and/or hor-
monetherapybesideradiotherapy.Occurrenceofzonazoster
after or during chemotherapy was also reported [10]. It was
claimed that adjuvant chemotherapy and immunosuppre-
ssant could facilitate herpes infection [10]. Other authors
highlightedthatthelocationofthelesionwaspredominantly
on the old radiotherapy side [5, 9]. In present case, zona
zoster lesion was located on the breast cancer side, and en-
larged lymph nodes were located in the opposite site of the
cancer. Enlarged lymph nodes may mimic malignant disease
as in our case, which could be primary tumor metastasis or
related to second primary. In both conditions patient pro-
gnosis and treatment is aﬀected. Of the patients with IMLN
identiﬁed, 10% contain metastatic disease [8]. Early dia-
gnosis of recurrence is important for disease control.
In the absence of classical fatty hilum and regular ovoid
cortex, radiological diﬀerential diagnosis of enlarged IMLNs
is not always possible. Mammography fails to identify over
half of the IMLNs visualized on sonography [11]. Detection
of metastatic IMLNs via breast imaging is focused on enlar-
gementofthenodesto1cm,andabsenceofthecentralecho-
genic/fatty hilum [11, 12]. In our case the detected masses
were smaller than 1cm and the central hilum was not pre-
sent. Detection based on these US characteristics has become
insuﬃcient as advances in technology demonstrate addi-
tional characteristic for further diﬀerentiation of smaller
masses.ThemajorityofthemetastaticIMLNsarereportedto
have an eccentrically displaced echogenic hilum with a ratio
of its volume to the total volume of the lymph node of less
than 50%, thickening of the nodal cortex, and pronounced
hypoechogenicity of the nodal cortex [11, 13]. However,
Edeiken-Monroe et al. [11] reported that, contrary to the
description in the literature, in their series most of the nodes
retained an oval appearance with lobular margins and no
signiﬁcant distal sound modulation as in our case.
On the morphologic analysis of MRI, the margins of
the observed masses in the presented case were smooth,
and lobular, which is associated with a 90–95% negative
predictive value for carcinoma [14–16]. On the contrary, the
intensity versus time curve showed fast enhancement with
washout, unlike benign lesions, which tend to have a gradualCase Reports in Oncological Medicine 3
Figure 2: On dynamic series, mass with smooth and lobular margin with an adjacent vessel is observed. Time intensity curve shows rapid
washin and minimal washout.
increase in enhancement. Various benign conditions which
produce contrast enhancement patterns that are hard to
distinguish from malignant processes may mimic malignant
lesions [14]. Nevertheless, 10%–20% of breast malignancies
are well-circumscribed masses [16]. Adjacent vessel sign is
an MRI sign indicative of malignancy and was observed in
our case [17, 18]. Breast MRI plays a substantial role in
distinguishing between well-circumscribed benign and mali-
gnant breast lesions. Mass lesions with washout on dynamic
series are generally considered malignant in a patient with
known malignancy [6]. However, extremely intense initial
enhancement during the ﬁrst 1-2 minutes that is well
above the usual range for invasive cancers is not typical
of carcinomas [6]. This ﬁnding was consistent with our
ﬁndings in this paper, and the masses were considered as en-
larged IMLNs caused by atypical zona zoster infection of the
contralateral mastectomy site. Cancers are less likely to show
thishighinitialpeak[6].TheenhancementpatternofIMLNs
in dynamic MRI series may mimic malignant lesions with
rapid initial increase and washout kinetics [6]. The complete
regressionoftheIMLNsaftertheantiviraltherapyconﬁrmed
our initial diagnosis.
In conclusion, in breast cancer patients, zona zoster
infectionmaypresentwithatypicalﬁndingsandcauseIMLN
enlargement on the opposite side. When breast US is not suf-
ﬁcient for the diﬀerential diagnosis, further assessment with
breast MRI may warrant proper diagnosis of IMLN enlarge-
ment.Thiswouldpreventunnecessarybiopsies,andantiviral
treatment with followup would be suﬃcient for manage-
ment.
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